Skip to main content
PMC home page
Gut logoLink to Gut
. 1975 Jun;16(6):490–499. doi: 10.1136/gut.16.6.490

Tumour immunology and the gut.

K C Calman
PMCID: PMC1411033  PMID: 50255

Abstract

This review set out to answer several questions related to tumour immunology and the gut. It is evident that in patients with gastrointestinal cancer there is a general depression of the immune response and this seems to be correlated with the stage of the disease. Paradoxically a specific immune response against definable tumour antigens can be demonstrated, both cellular and humoral mechanisms being involved although the complexities of this paradox require further analysis. Immunotherapy has been employed in gastrointestinal tumours in a sporadic way. The results suggest that gastrointestinal neoplasms may respond at least as well as other tumours. A firm conclusion awaits the results of controlled trials in which the bulk of the tumour has been effectively dealt with by other means or where combined immunochemotherapy is being used.

Full text

PDF
490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelev G. I. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res. 1971;14:295–358. doi: 10.1016/s0065-230x(08)60523-0. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. M., De Sousa M. A., Halnan K. E., Kelly F., Hannah G. Assessment of immunization by autotransplantation of human cancer. Br J Surg. 1970 Aug;57(8):557–561. doi: 10.1002/bjs.1800570802. [DOI] [PubMed] [Google Scholar]
  3. BLACK M. M., OPLER S. R., SPEER F. D. Microscopic structure of gastric carcinomas and their regional lymph nodes in relation to survival. Surg Gynecol Obstet. 1954 Jun;98(6):725–734. [PubMed] [Google Scholar]
  4. Baldwin R. W., Embleton M. J. Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas. Int J Cancer. 1971 Jan 15;7(1):17–25. doi: 10.1002/ijc.2910070103. [DOI] [PubMed] [Google Scholar]
  5. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  6. Banwo O., Versey J., Hobbs J. R. New oncofetal antigen for human pancreas. Lancet. 1974 Apr;1(7859):643–645. doi: 10.1016/s0140-6736(74)93197-3. [DOI] [PubMed] [Google Scholar]
  7. Barry R. E., Read A. E. Coeliac disease and malignancy. Q J Med. 1973 Oct;42(168):665–675. [PubMed] [Google Scholar]
  8. Bleumink E., Nater J. P., Schraffordt Koops H., The T. H. A standrard method for DNCB sensitization testing in patients with neoplasms. Cancer. 1974 Apr;33(4):911–915. doi: 10.1002/1097-0142(197404)33:4<911::aid-cncr2820330404>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  9. Bone G., Lauder I. Cellular immunity, peripheral blood lymphocyte count and pathological staging of tumours in the gastrointestinal tract. Br J Cancer. 1974 Sep;30(3):215–221. doi: 10.1038/bjc.1974.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bull D. M., Leibach J. R., Williams M. A., Helms R. A. Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration. Science. 1973 Sep 7;181(4103):957–959. doi: 10.1126/science.181.4103.957. [DOI] [PubMed] [Google Scholar]
  11. Calman K. C. Why are small bowel tumours rare? An experimental model. Gut. 1974 Jul;15(7):552–554. doi: 10.1136/gut.15.7.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Castro J. E., Cass W. Maintenance of human tumours and tissues in immunosuppressed mice. Br J Surg. 1974 Jun;61(6):421–426. doi: 10.1002/bjs.1800610602. [DOI] [PubMed] [Google Scholar]
  13. Castro J. E. Human tumours grown in mice. Nat New Biol. 1972 Sep 20;239(90):83–84. doi: 10.1038/newbio239083a0. [DOI] [PubMed] [Google Scholar]
  14. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  15. Chakravorty R. C., Curutchet H. P., Coppolla F. S., Park C. M., Blaylock W. K., Lawrence W., Jr The delayed hypersensitivity reaction in cancer patient: observations on sensitization by DNCB. Surgery. 1973 May;73(5):730–735. [PubMed] [Google Scholar]
  16. Chretien P. B., Crowder W. L., Gertner H. R., Sample W. F., Catalona W. J. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Surg Gynecol Obstet. 1973 Mar;136(3):380–384. [PubMed] [Google Scholar]
  17. Cobb L. M. The hamster as a host for the growth and study of human tumor cell populations. Cancer Res. 1974 May;34(5):958–963. [PubMed] [Google Scholar]
  18. Cochran A. J., Spilg W. G., Mackie R. M., Thomas C. E. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J. 1972 Oct 14;4(5832):67–70. [PMC free article] [PubMed] [Google Scholar]
  19. Costanza M. E., Das S., Nathanson L., Rule A., Schwartz R. S. Proceedings: Carcinoembryonic antigen. Report of a screening study. Cancer. 1974 Feb;33(2):583–590. doi: 10.1002/1097-0142(197402)33:2<583::aid-cncr2820330238>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  20. Costanza M. E., Pinn V., Schwartz R. S., Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med. 1973 Sep 6;289(10):520–522. doi: 10.1056/NEJM197309062891007. [DOI] [PubMed] [Google Scholar]
  21. Currie G. A. Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer. Br J Cancer. 1972 Jun;26(3):141–153. doi: 10.1038/bjc.1972.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Davies A. J., Leuchars E., Wallis V., Koller P. C. The mitotic response of thymus-derived cells to antigenic stimulus. Transplantation. 1966 Jul;4(4):438–451. doi: 10.1097/00007890-196607000-00008. [DOI] [PubMed] [Google Scholar]
  23. Deutsch E., Apffel C. A., Mori H., Walker J. E. A tumor-associated antigen in gastric cancer secretions. Cancer Res. 1973 Jan;33(1):112–116. [PubMed] [Google Scholar]
  24. Dhar P., Moore T., Zamcheck N., Kupchik H. Z. Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA. 1972 Jul 3;221(1):31–35. [PubMed] [Google Scholar]
  25. Dikman S. H., Toker C. Enteroblastoma complicating regional enteritis. Gastroenterology. 1973 Sep;65(3):462–466. [PubMed] [Google Scholar]
  26. Edelman R., Suskind R., Olson R. E., Sirisinha S. Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. Lancet. 1973 Mar 10;1(7802):506–508. doi: 10.1016/s0140-6736(73)90326-7. [DOI] [PubMed] [Google Scholar]
  27. Edwards A. J., Rowland G. F., Lee M. R. Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer. Lancet. 1973 Mar 31;1(7805):687–689. doi: 10.1016/s0140-6736(73)91477-3. [DOI] [PubMed] [Google Scholar]
  28. Eilber F. R., Morton D. L. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  29. Elgort D. A., Abelev G. I., O'Conor G. T. Dependence of the specificity of the serologic test for primary liver cancer in different areas of the world on sensitivity of the method used for detecting alpha-fetoprotein. Int J Cancer. 1972 Sep 15;10(2):331–337. doi: 10.1002/ijc.2910100214. [DOI] [PubMed] [Google Scholar]
  30. Evans J. T., Hauschka T. S., Mittelman A. Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethylhydrazine. J Natl Cancer Inst. 1974 Mar;52(3):999–1000. doi: 10.1093/jnci/52.3.999. [DOI] [PubMed] [Google Scholar]
  31. Fairley G. H. Immunity to malignant disease in man. Br Med J. 1969 May 24;2(5655):467–473. doi: 10.1136/bmj.2.5655.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Garmaise A. B., Rogers A. E., Newberne P. M., Saravis C. A., Kupchik H. Z., Zamcheck N. Immunological detection of antigen(s) associated with rat colon carcinoma. Nature. 1974 Apr 19;248(5450):706–707. doi: 10.1038/248706a0. [DOI] [PubMed] [Google Scholar]
  33. Ghose T., Norvell S. T., Guclu A., Cameron D., Bodurtha A., MacDonald A. S. Immunochemotherapy of cancer with chlorambucil-carrying antibody. Br Med J. 1972 Aug 26;3(5825):495–499. doi: 10.1136/bmj.3.5825.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Goldenberg D. M., Hansen H. J. Carcinoembryonic antigen present in human colonic neoplasms serially propagated in hamsters. Science. 1972 Mar 10;175(4026):1117–1118. [PubMed] [Google Scholar]
  35. Griffen W. O., Jr, Jewell W. R., Meeker W. R., Humphrey L. J. New concepts of cancer of the colon and rectum: immunotherapy for patients with cancer of the large intestine. Dis Colon Rectum. 1972 Mar-Apr;15(2):116–119. doi: 10.1007/BF02587258. [DOI] [PubMed] [Google Scholar]
  36. Guillou P. J., Brennan T. G., Giles G. R. Phytohaemagglutinin-stimulated transformation of peripheral and lymph-node lymphocytes in patients with gastro-intestinal cancer. Br J Surg. 1973 Sep;60(9):745–749. doi: 10.1002/bjs.1800600924. [DOI] [PubMed] [Google Scholar]
  37. Guillou P. J., Giles G. R. Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum. Gut. 1973 Sep;14(9):733–738. doi: 10.1136/gut.14.9.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hartmann D., Lewis M. G. Presence and possible role of anti-IgG antibodies in human malignancy. Lancet. 1974 Jun 29;1(7870):1318–1320. doi: 10.1016/s0140-6736(74)90684-9. [DOI] [PubMed] [Google Scholar]
  39. Hellström I., Hellström K. E. Newer concepts of cancer of the colon and rectum: cellular immunity to human colonic carcinomas. Dis Colon Rectum. 1972 Mar-Apr;15(2):100–105. doi: 10.1007/BF02587253. [DOI] [PubMed] [Google Scholar]
  40. Hellström I., Hellström K. E., Shepard T. H. Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium. Int J Cancer. 1970 Nov 15;6(3):346–351. doi: 10.1002/ijc.2910060304. [DOI] [PubMed] [Google Scholar]
  41. Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer. 1971 Jan 15;7(1):1–16. doi: 10.1002/ijc.2910070102. [DOI] [PubMed] [Google Scholar]
  42. Hellström I., Hellström K. E. Some aspects of the immune defense against cancer. II. In vitro studies on human tumors. Cancer. 1971 Nov;28(5):1269–1271. doi: 10.1002/1097-0142(1971)28:5<1269::aid-cncr2820280526>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  43. Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
  44. Higgins G. A., Dwight R. W., Smith J. V., Keehn R. J. Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch Surg. 1971 Apr;102(4):339–343. doi: 10.1001/archsurg.1971.01350040101020. [DOI] [PubMed] [Google Scholar]
  45. Hollinshead A., Glew D., Bunnag B., Gold P., Herberman R. Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. Lancet. 1970 Jun 6;1(7658):1191–1195. doi: 10.1016/s0140-6736(70)91784-8. [DOI] [PubMed] [Google Scholar]
  46. Hughes L. E., Mackay W. D. Suppression of the tuberculin response in malignant disease. Br Med J. 1965 Dec 4;2(5474):1346–1348. doi: 10.1136/bmj.2.5474.1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Humphrey L. J., Jewell W. R., Murray D. R., Griffen W. O., Jr Immunotherapy for the patient with cancer. Ann Surg. 1971 Jan;173(1):47–54. doi: 10.1097/00000658-197101000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Humphrey L. J., Murray D. R., Boehm O. R. Effect of tumor vaccines in immunizing patients with cancer. Surg Gynecol Obstet. 1971 Mar;132(3):437–442. [PubMed] [Google Scholar]
  49. Humphrey L. J. Tumor immunity. J Surg Res. 1970 Oct;10(10):493–512. doi: 10.1016/0022-4804(70)90075-2. [DOI] [PubMed] [Google Scholar]
  50. Hunt J. S., Silverstein M. J., Sparks F. C., Haskell C. M., Pilch Y. H., Morton D. L. Granulomatous hepatitis: a complication of B.C.G. immunotherapy. Lancet. 1973 Oct 13;2(7833):820–821. doi: 10.1016/s0140-6736(73)90860-x. [DOI] [PubMed] [Google Scholar]
  51. Johnson M. W., Maibach H. I., Salmon S. E. Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med. 1971 Jun 3;284(22):1255–1257. doi: 10.1056/NEJM197106032842210. [DOI] [PubMed] [Google Scholar]
  52. Kawasaki H., Imasato K., Kimoto E., Akiyama K., Takeuchi M. Immunohistological studies on intestinal mucosaspecific glycoprotein in gastric carcinoma. Gan. 1972 Apr;63(2):231–237. [PubMed] [Google Scholar]
  53. Kim U. S., Papatestas A. E. Letter: Peripheral lymphocyte counts in colonic disease. Lancet. 1974 Aug 24;2(7878):462–463. doi: 10.1016/s0140-6736(74)91843-1. [DOI] [PubMed] [Google Scholar]
  54. Krakoff I. H. Chemotherapy of gastrointestinal cancer. Cancer. 1972 Dec;30(6):1600–1603. doi: 10.1002/1097-0142(197212)30:6<1600::aid-cncr2820300628>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  55. Kronman B. S., Shapiro H. M., Localio S. A. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors. Dis Colon Rectum. 1972 Mar-Apr;15(2):106–110. doi: 10.1007/BF02587255. [DOI] [PubMed] [Google Scholar]
  56. Kumar S., Taylor G. Letter: Effect of surgery on lymphocytotoxicity against tumour cells. Lancet. 1974 Dec 28;2(7896):1564–1565. doi: 10.1016/s0140-6736(74)90301-8. [DOI] [PubMed] [Google Scholar]
  57. LYTTON B., HUGHES L. E., FULTHORPE A. J. CIRCULATING ANTIBODY RESPONSE IN MALIGNANT DISEASE. Lancet. 1964 Jan 11;1(7324):69–71. doi: 10.1016/s0140-6736(64)91390-x. [DOI] [PubMed] [Google Scholar]
  58. Lauder I., Bone G. Lymphocyte transformation in large bowel cancer. Br J Cancer. 1973 May;27(5):409–413. doi: 10.1038/bjc.1973.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Laurence D. J., Neville A. M. Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer. 1972 Oct;26(5):335–355. doi: 10.1038/bjc.1972.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Laurence D. J., Stevens U., Bettelheim R., Darcy D., Leese C., Turberville C., Alexander P., Johns E. W., Neville A. M. Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J. 1972 Sep 9;3(5827):605–609. doi: 10.1136/bmj.3.5827.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Lee J. C., Yamauchi H., Hopper J., Jr The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966 Jan;64(1):41–51. doi: 10.7326/0003-4819-64-1-41. [DOI] [PubMed] [Google Scholar]
  62. Lewis M. G., Loughridge L. W., Phillips T. M. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet. 1971 Jul 17;2(7716):134–135. doi: 10.1016/s0140-6736(71)92305-1. [DOI] [PubMed] [Google Scholar]
  63. Lowenfels A. B. Why are small-bowel tumours so rare? Lancet. 1973 Jan 6;1(7793):24–26. doi: 10.1016/s0140-6736(73)91228-2. [DOI] [PubMed] [Google Scholar]
  64. Mach J. P., Carrel S., Merenda C., Sordat B., Cerottini J. C. In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature. 1974 Apr 19;248(5450):704–706. doi: 10.1038/248704a0. [DOI] [PubMed] [Google Scholar]
  65. Mach J. P., Jaeger P., Bertholet M. M., Ruegsegger C. H., Loosli R. M., Pettavel J. Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet. 1974 Sep 7;2(7880):535–540. doi: 10.1016/s0140-6736(74)91872-8. [DOI] [PubMed] [Google Scholar]
  66. Mackay A. M., Patel S., Carter S., Stevens U., Laurence D. J., Cooper E. H., Neville A. M. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J. 1974 Nov 16;4(5941):382–385. doi: 10.1136/bmj.4.5941.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Mathews J. D., Mackay I. R., Whittingham S., Malcolm L. A. Protein supplementation and enhanced antibody-producing capacity in New Guinean school-children. Lancet. 1972 Sep 30;2(7779):675–677. doi: 10.1016/s0140-6736(72)92086-7. [DOI] [PubMed] [Google Scholar]
  68. Mavligit G. M., Ambus U., Gutterman J. U., Hersh E. M., McBride C. M. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity. Nat New Biol. 1973 Jun 6;243(127):188–190. doi: 10.1038/newbio243188a0. [DOI] [PubMed] [Google Scholar]
  69. Mavligit G. M., Guttermann J. U., Burgess M. A., Speer J. F., Reed R. C., Martin R. C., McBride C. M., Copeland E. M., Gehan E. A., Hersh E. M. Immunotherapy: its possible application in the management of large-bowel cancer. Am J Dig Dis. 1974 Nov;19(11):1047–1053. doi: 10.1007/BF01255789. [DOI] [PubMed] [Google Scholar]
  70. McFarlane H., Hamid J. Cell-mediated immune response in malnutrition. Clin Exp Immunol. 1973 Jan;13(1):153–164. [PMC free article] [PubMed] [Google Scholar]
  71. McIllmurray M. B., Gray M., Langman M. J. Phytohaemagglutinin-induced lymphocyte transformation in patients before and after resection of large intestinal cancer. Gut. 1973 Jul;14(7):541–544. doi: 10.1136/gut.14.7.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. McIllmurray M. B., Price M. R., Langman M. J. Inhibition of leucocyte migration in patients with large intestinal cancer by extracts prepared from large intestinal tumours and from normal colonic mucosa. Br J Cancer. 1974 Apr;29(4):305–311. doi: 10.1038/bjc.1974.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Nadler S. H., Moore G. E. Immunotherapy of malignant disease. Arch Surg. 1969 Sep;99(3):376–381. doi: 10.1001/archsurg.1969.01340150084016. [DOI] [PubMed] [Google Scholar]
  74. Nairn R. C., Nind A. P., Guli E. P., Davies D. J., Rolland J. M., McGiven A. R., Hughes E. S. Immunological reactivity in patients with carcinoma of colon. Br Med J. 1971 Dec 18;4(5789):706–709. doi: 10.1136/bmj.4.5789.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Nelson H. S. Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens. J Natl Cancer Inst. 1969 May;42(5):765–770. [PubMed] [Google Scholar]
  76. Park S. K., Brody J. I., Wallace H. A., Blakemore W. S. Immunosuppressive effect of surgery. Lancet. 1971 Jan 9;1(7689):53–55. doi: 10.1016/s0140-6736(71)90777-x. [DOI] [PubMed] [Google Scholar]
  77. Pemberton P. J. Adult celiac disease, reticulosis and carcinoma. Am J Dig Dis. 1972 Sep;17(9):851–855. doi: 10.1007/BF02231160. [DOI] [PubMed] [Google Scholar]
  78. Pickard R. G., Cobb L. M., Steel G. G. The growth kinetics of xenografts of human colorectal tumours in immune deprived mice. Br J Cancer. 1975 Jan;31(1):36–45. doi: 10.1038/bjc.1975.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Prehn R. T., Lappé M. A. An immunostimulation theory of tumor development. Transplant Rev. 1971;7:26–54. doi: 10.1111/j.1600-065x.1971.tb00462.x. [DOI] [PubMed] [Google Scholar]
  80. Ravry M., McIntire K. R., Moertel C. G., Waldmann T. A., Schutt A. J., Go V. L. Carcinoembryonic antigen and alpha-fetoprotein in the diagnosis of gastric and colonic cancer: a comparative clinical evaluation. J Natl Cancer Inst. 1974 Mar;52(3):1019–1024. doi: 10.1093/jnci/52.3.1019. [DOI] [PubMed] [Google Scholar]
  81. Reitemeier R. J., Moertel C. G., Hahn R. G. Combination chemotherapy in gastrointestinal cancer. Cancer Res. 1970 May;30(5):1425–1428. [PubMed] [Google Scholar]
  82. Riddle P. R., Berenbaum M. C. Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet. 1967 Apr 8;1(7493):746–748. doi: 10.1016/s0140-6736(67)91364-5. [DOI] [PubMed] [Google Scholar]
  83. Roswit B., Higgins G. A., Humphrey E. W., Robinette C. D. Preoperative irradiation of operable adenocarcinoma of the rectum and rectosigmoid colon. Radiology. 1973 Aug;108(2):389–395. doi: 10.1148/108.2.389. [DOI] [PubMed] [Google Scholar]
  84. Rubens R. D. Antibodies as carriers of anticancer agents. Lancet. 1974 Mar 23;1(7856):498–499. doi: 10.1016/s0140-6736(74)92799-8. [DOI] [PubMed] [Google Scholar]
  85. Sherlock P., Ehrlich A. N., Winawer S. J. Diagnosis of gastrointestinal cancer: current status and recent progress. Gastroenterology. 1972 Oct;63(4):672–700. [PubMed] [Google Scholar]
  86. Sirisinha S., Edelman R., Suskind R., Charupatana C., Olson R. E. Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. Lancet. 1973 May 12;1(7811):1016–1020. doi: 10.1016/s0140-6736(73)90663-6. [DOI] [PubMed] [Google Scholar]
  87. Sjögren H. O. Immunobiology of colon carcinomas. Am J Dig Dis. 1974 Nov;19(11):1033–1035. doi: 10.1007/BF01255786. [DOI] [PubMed] [Google Scholar]
  88. Sokal J. E., Aungst C. W., Snyderman M. Delay in progression of malignant lymphoma after BCG vaccination. N Engl J Med. 1974 Dec 5;291(23):1226–1230. doi: 10.1056/NEJM197412052912305. [DOI] [PubMed] [Google Scholar]
  89. Sophocles A. M., Jr, Nadler S. H. Immunologic aspects of cancer. Surg Gynecol Obstet. 1971 Aug;133(2):321–331. [PubMed] [Google Scholar]
  90. Steele G., Jr, Sjögren H. O. Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas. Cancer Res. 1974 Aug;34(8):1801–1807. [PubMed] [Google Scholar]
  91. Stewart T. H. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon. Cancer. 1969 Jun;23(6):1368–1379. doi: 10.1002/1097-0142(196906)23:6<1368::aid-cncr2820230619>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  92. Stillman A., Zamcheck N. Recent advances in immunologic diagnosis of digestive tract cancer. Am J Dig Dis. 1970 Nov;15(11):1003–1018. doi: 10.1007/BF02232820. [DOI] [PubMed] [Google Scholar]
  93. Suciu-Foca N., Buda J., McManus J., Thiem T., Reemtsma K. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res. 1973 Oct;33(10):2373–2377. [PubMed] [Google Scholar]
  94. Sutherland R. M., Inch W. R., McCredie J. A. Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer. Cancer. 1971 Mar;27(3):574–578. doi: 10.1002/1097-0142(197103)27:3<574::aid-cncr2820270310>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  95. Symes M. O., Riddell A. G. The use of immunized pig lymph-node cells in the treatment of patients with advanced malignant disease. Br J Surg. 1973 Mar;60(3):176–180. doi: 10.1002/bjs.1800600303. [DOI] [PubMed] [Google Scholar]
  96. Symes M. O. Tumour immunology. Br J Surg. 1974 Dec;61(12):929–938. doi: 10.1002/bjs.1800611202. [DOI] [PubMed] [Google Scholar]
  97. Tannenberg A. E., Muller H. K., Cauchi M. N., Nairn R. C. Incidence of autoantibodies in cancer patients. Clin Exp Immunol. 1973 Oct;15(2):153–156. [PMC free article] [PubMed] [Google Scholar]
  98. Taylor G., Odili J. L. Histological evidence of tumour rejection after active immunotherapy in human malignant disease. Br Med J. 1972 Apr 22;2(5807):183–188. doi: 10.1136/bmj.2.5807.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Thomas G. G., Fox M. Depression of immune responsiveness in breast and large-bowel tumours as measured by heterophile antibody activity. Br J Surg. 1973 May;60(5):352–355. doi: 10.1002/bjs.1800600507. [DOI] [PubMed] [Google Scholar]
  100. Thurnherr N., Deschner E. E., Stonehill E. H., Lipkin M. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res. 1973 May;33(5):940–945. [PubMed] [Google Scholar]
  101. Weedon D. D., Shorter R. G., Ilstrup D. M., Huizenga K. A., Taylor W. F. Crohn's disease and cancer. N Engl J Med. 1973 Nov 22;289(21):1099–1103. doi: 10.1056/NEJM197311222892101. [DOI] [PubMed] [Google Scholar]
  102. Wolf P. L., Vazquez J., Czajkowski N. P., Rosenblatt M. A new method of active immunisation to autologous human tumour tissue. Lancet. 1967 Oct 28;2(7522):905–909. doi: 10.1016/s0140-6736(67)90229-2. [DOI] [PubMed] [Google Scholar]
  103. Wortis H. H. Immunological studies of nude mice. Contemp Top Immunobiol. 1974;3:243–263. doi: 10.1007/978-1-4684-3045-5_10. [DOI] [PubMed] [Google Scholar]
  104. de Boer W. G., Forsyth A., Nairn R. C. Gastric antigens in health and disease. Behaviour in early development, senescence, metaplasia, and cancer. Br Med J. 1969 Jul 12;3(5662):93–94. doi: 10.1136/bmj.3.5662.93. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES